A Cross-Sectional, Questionnaire-Based Study on Drug Treatment Awareness in Schizophrenia Patients and Caregivers: An Unexplored Avenue
Background: Schizophrenia is associated with high relapse rates, and medication nonadherence is a major factor contributing toward relapse. Since medication adherence and treatment awareness are linked, an alarming need was felt to evaluate the level of drug treatment awareness in patients who have...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2022-03-01
|
| Series: | Indian Journal of Psychological Medicine |
| Online Access: | https://doi.org/10.1177/02537176211056358 |
| _version_ | 1818286022236045312 |
|---|---|
| author | Raakhi Tripathi Sharmila Jalgaonkar Snehalata Gajbhiye Nishtha Khatri Mohsin Sayyed Shubhangi Parkar |
| author_facet | Raakhi Tripathi Sharmila Jalgaonkar Snehalata Gajbhiye Nishtha Khatri Mohsin Sayyed Shubhangi Parkar |
| author_sort | Raakhi Tripathi |
| collection | DOAJ |
| description | Background: Schizophrenia is associated with high relapse rates, and medication nonadherence is a major factor contributing toward relapse. Since medication adherence and treatment awareness are linked, an alarming need was felt to evaluate the level of drug treatment awareness in patients who have schizophrenia. Besides, patients who have schizophrenia are often dependent on their caregivers for medications. Hence, the current study was also designed to look into drug treatment awareness among caregivers. Methods: This was a cross-sectional, questionnaire-based study. Patients diagnosed with schizophrenia as per The Diagnostic and Statistical Manual of Mental Disorders , Fifth Edition were included, provided they had good insight and had been prescribed medications at the study center for at least three months. Caregivers were included using the Pollak and Perlick criteria. The sociodemographic profile of the patients and caregivers was recorded, and further assessment for treatment awareness was done using the prevalidated Drug Treatment Awareness Questionnaire (DTAQ). Results: A total of 166 patients and 157 caregivers were enrolled. Mean drug awareness scores among patients and caregivers did not show statistically significant differences (P= 0.22). Mean ± SD DTAQ awareness scores in patients and caregivers were 12.57 ± 1.81 and 12.84 ± 1.91, respectively. The majority of patients and caregivers (> 90%) possessed awareness in domains related to past medication records and in that of re-visit/re-contact instructions. Awareness was least commonly seen in relation to side effects of medications and details of the prescribed medications, where only about 50% of patients and caregivers possessed awareness. No clinically significant correlation was found between sociodemographic factors and drug treatment awareness scores. Conclusion: Drug treatment awareness in patients and caregivers was comparable and was not reliant on the sociodemographic factors. Special interventions should be conducted to raise drug treatment awareness among patients having insight and their caregivers. |
| first_indexed | 2024-12-13T01:17:59Z |
| format | Article |
| id | doaj.art-11ee3711df0e465aa4661eaaa6d18be9 |
| institution | Directory Open Access Journal |
| issn | 0253-7176 0975-1564 |
| language | English |
| last_indexed | 2024-12-13T01:17:59Z |
| publishDate | 2022-03-01 |
| publisher | SAGE Publishing |
| record_format | Article |
| series | Indian Journal of Psychological Medicine |
| spelling | doaj.art-11ee3711df0e465aa4661eaaa6d18be92022-12-22T00:04:17ZengSAGE PublishingIndian Journal of Psychological Medicine0253-71760975-15642022-03-014410.1177/02537176211056358A Cross-Sectional, Questionnaire-Based Study on Drug Treatment Awareness in Schizophrenia Patients and Caregivers: An Unexplored AvenueRaakhi Tripathi0Sharmila Jalgaonkar1Snehalata Gajbhiye2Nishtha Khatri3Mohsin Sayyed4Shubhangi Parkar5 Dept. of Pharmacology and Therapeutics, Seth G.S. Medical College and King Edward Memorial Hospital, Mumbai, Maharashtra, India. Dept. of Pharmacology and Therapeutics, Seth G.S. Medical College and King Edward Memorial Hospital, Mumbai, Maharashtra, India. Dept. of Pharmacology and Therapeutics, Seth G.S. Medical College and King Edward Memorial Hospital, Mumbai, Maharashtra, India. Dept. of Pharmacology and Therapeutics, Seth G.S. Medical College and King Edward Memorial Hospital, Mumbai, Maharashtra, India. Dept. of Pharmacology and Therapeutics, Seth G.S. Medical College and King Edward Memorial Hospital, Mumbai, Maharashtra, India. Dept. of Psychiatry, Seth G.S. Medical College and King Edward Memorial Hospital, Mumbai, Maharashtra, India.Background: Schizophrenia is associated with high relapse rates, and medication nonadherence is a major factor contributing toward relapse. Since medication adherence and treatment awareness are linked, an alarming need was felt to evaluate the level of drug treatment awareness in patients who have schizophrenia. Besides, patients who have schizophrenia are often dependent on their caregivers for medications. Hence, the current study was also designed to look into drug treatment awareness among caregivers. Methods: This was a cross-sectional, questionnaire-based study. Patients diagnosed with schizophrenia as per The Diagnostic and Statistical Manual of Mental Disorders , Fifth Edition were included, provided they had good insight and had been prescribed medications at the study center for at least three months. Caregivers were included using the Pollak and Perlick criteria. The sociodemographic profile of the patients and caregivers was recorded, and further assessment for treatment awareness was done using the prevalidated Drug Treatment Awareness Questionnaire (DTAQ). Results: A total of 166 patients and 157 caregivers were enrolled. Mean drug awareness scores among patients and caregivers did not show statistically significant differences (P= 0.22). Mean ± SD DTAQ awareness scores in patients and caregivers were 12.57 ± 1.81 and 12.84 ± 1.91, respectively. The majority of patients and caregivers (> 90%) possessed awareness in domains related to past medication records and in that of re-visit/re-contact instructions. Awareness was least commonly seen in relation to side effects of medications and details of the prescribed medications, where only about 50% of patients and caregivers possessed awareness. No clinically significant correlation was found between sociodemographic factors and drug treatment awareness scores. Conclusion: Drug treatment awareness in patients and caregivers was comparable and was not reliant on the sociodemographic factors. Special interventions should be conducted to raise drug treatment awareness among patients having insight and their caregivers.https://doi.org/10.1177/02537176211056358 |
| spellingShingle | Raakhi Tripathi Sharmila Jalgaonkar Snehalata Gajbhiye Nishtha Khatri Mohsin Sayyed Shubhangi Parkar A Cross-Sectional, Questionnaire-Based Study on Drug Treatment Awareness in Schizophrenia Patients and Caregivers: An Unexplored Avenue Indian Journal of Psychological Medicine |
| title | A Cross-Sectional, Questionnaire-Based Study on Drug Treatment Awareness in Schizophrenia Patients and Caregivers: An Unexplored Avenue |
| title_full | A Cross-Sectional, Questionnaire-Based Study on Drug Treatment Awareness in Schizophrenia Patients and Caregivers: An Unexplored Avenue |
| title_fullStr | A Cross-Sectional, Questionnaire-Based Study on Drug Treatment Awareness in Schizophrenia Patients and Caregivers: An Unexplored Avenue |
| title_full_unstemmed | A Cross-Sectional, Questionnaire-Based Study on Drug Treatment Awareness in Schizophrenia Patients and Caregivers: An Unexplored Avenue |
| title_short | A Cross-Sectional, Questionnaire-Based Study on Drug Treatment Awareness in Schizophrenia Patients and Caregivers: An Unexplored Avenue |
| title_sort | cross sectional questionnaire based study on drug treatment awareness in schizophrenia patients and caregivers an unexplored avenue |
| url | https://doi.org/10.1177/02537176211056358 |
| work_keys_str_mv | AT raakhitripathi acrosssectionalquestionnairebasedstudyondrugtreatmentawarenessinschizophreniapatientsandcaregiversanunexploredavenue AT sharmilajalgaonkar acrosssectionalquestionnairebasedstudyondrugtreatmentawarenessinschizophreniapatientsandcaregiversanunexploredavenue AT snehalatagajbhiye acrosssectionalquestionnairebasedstudyondrugtreatmentawarenessinschizophreniapatientsandcaregiversanunexploredavenue AT nishthakhatri acrosssectionalquestionnairebasedstudyondrugtreatmentawarenessinschizophreniapatientsandcaregiversanunexploredavenue AT mohsinsayyed acrosssectionalquestionnairebasedstudyondrugtreatmentawarenessinschizophreniapatientsandcaregiversanunexploredavenue AT shubhangiparkar acrosssectionalquestionnairebasedstudyondrugtreatmentawarenessinschizophreniapatientsandcaregiversanunexploredavenue AT raakhitripathi crosssectionalquestionnairebasedstudyondrugtreatmentawarenessinschizophreniapatientsandcaregiversanunexploredavenue AT sharmilajalgaonkar crosssectionalquestionnairebasedstudyondrugtreatmentawarenessinschizophreniapatientsandcaregiversanunexploredavenue AT snehalatagajbhiye crosssectionalquestionnairebasedstudyondrugtreatmentawarenessinschizophreniapatientsandcaregiversanunexploredavenue AT nishthakhatri crosssectionalquestionnairebasedstudyondrugtreatmentawarenessinschizophreniapatientsandcaregiversanunexploredavenue AT mohsinsayyed crosssectionalquestionnairebasedstudyondrugtreatmentawarenessinschizophreniapatientsandcaregiversanunexploredavenue AT shubhangiparkar crosssectionalquestionnairebasedstudyondrugtreatmentawarenessinschizophreniapatientsandcaregiversanunexploredavenue |